The brands are interchangeable at equivalent doses
For licensed GLP-1 receptor agonist medicines used for weight management (Wegovy and Saxenda), the side effect profile is well characterised in their UK Summaries of Product Characteristics (SmPCs), available via the electronic Medicines Compendium (emc)
The Bottom Line GLP-1 medications affect iron absorption through three interconnected mechanisms: delayed gastric emptying reduces the time iron spends in optimal absorption zones, appetite suppression decreases total iron intake, and metabolic changes may alter how your body stores and utilizes iron after absorption
BPC-157 is believed to work through multiple mechanisms, including upregulation of growth hormone receptors, modulation of nitric oxide synthesis, and interaction with the dopaminergic system
LegitScript certified Verified for safe, compliant telehealth and pharmacy practice